1. Cell Biology

A bioactive peptide amidating enzyme is required for ciliogenesis

  1. Dhivya Kumar
  2. Daniela Strenkert
  3. Ramila S Patel-King
  4. Michael T Leonard
  5. Sabeeha S Merchant
  6. Richard E Mains
  7. Stephen M King  Is a corresponding author
  8. Betty A Eipper  Is a corresponding author
  1. University of Connecticut Health Center, United States
  2. University of California Los Angeles, United States
  3. University of California, Los Angeles, United States
https://doi.org/10.7554/eLife.25728
Share this article
Cite this article
  1. Dhivya Kumar
  2. Daniela Strenkert
  3. Ramila S Patel-King
  4. Michael T Leonard
  5. Sabeeha S Merchant
  6. Richard E Mains
  7. Stephen M King
  8. Betty A Eipper
(2017)
A bioactive peptide amidating enzyme is required for ciliogenesis
eLife 6:e25728.
https://doi.org/10.7554/eLife.25728
  2. Download BibTeX
  3. Download .RIS

Abstract

The pathways controlling cilium biogenesis in different cell types have not been fully elucidated. We recently identified peptidylglycine α-amidating monooxygenase (PAM), an enzyme required for generating amidated bioactive signaling peptides, in Chlamydomonas and mammalian cilia. Here, we show that PAM is required for the normal assembly of motile and primary cilia in Chlamydomonas, planaria and mice. Chlamydomonas PAM knockdown lines failed to assemble cilia beyond the transition zone, had abnormal Golgi architecture and altered levels of cilia assembly components. Decreased PAM gene expression reduced motile ciliary density on the ventral surface of planaria and resulted in the appearance of cytosolic axonemes lacking a ciliary membrane. The architecture of primary cilia on neuroepithelial cells in Pam-/- mouse embryos was also aberrant. Our data suggest that PAM activity and alterations in post-Golgi trafficking contribute to the observed ciliogenesis defects and provide an unanticipated, highly conserved, link between PAM, amidation and ciliary assembly.

Article and author information

Author details

  1. Dhivya Kumar

    Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3737-014X

  2. Daniela Strenkert

    Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.

  3. Ramila S Patel-King

    Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Michael T Leonard

    Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Sabeeha S Merchant

    Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Richard E Mains

    Department of Neuroscience, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. Stephen M King

    Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, United States
    For correspondence
    king@uchc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5484-5530

  8. Betty A Eipper

    Department of Neuroscience, University of Connecticut Health Center, Farmington, United States
    For correspondence
    eipper@uchc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1171-5557

Funding

National Institutes of Health (DK032949)

  • Betty A Eipper

National Institutes of Health (GM051293)

  • Stephen M King

National Institutes of Health (GM042143)

  • Sabeeha S Merchant

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures involving mice were approved by the UCHC Institutional Animal Care and Use Committee (protocol 101529-1119), in accordance with National Institutes of Health and ARRIVE guidelines (https://www. nc3rs.org.uk/arrive-guidelines).

Reviewing Editor

  1. Anna Akhmanova, Utrecht University, Netherlands

Publication history

  1. Received: February 3, 2017
  2. Accepted: May 15, 2017
  3. Accepted Manuscript published: May 17, 2017 (version 1)
  4. Version of Record published: June 6, 2017 (version 2)
  5. Version of Record updated: June 16, 2017 (version 3)

Copyright

© 2017, Kumar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,674
    Page views
  • 375
    Downloads
  • 18
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dhivya Kumar
  2. Daniela Strenkert
  3. Ramila S Patel-King
  4. Michael T Leonard
  5. Sabeeha S Merchant
  6. Richard E Mains
  7. Stephen M King
  8. Betty A Eipper
(2017)
A bioactive peptide amidating enzyme is required for ciliogenesis
eLife 6:e25728.
https://doi.org/10.7554/eLife.25728

Categories and tags

Research organism

Further reading

    1. Cell Biology
    2. Medicine

    SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients

    Eric N Jimenez-Vazquez et al.
    Research Article

    Background:

    Patients with cardiomyopathy of Duchenne Muscular Dystrophy (DMD) are at risk of developing life-threatening arrhythmias, but the mechanisms are unknown. We aimed to determine the role of ion channels controlling cardiac excitability in the mechanisms of arrhythmias in DMD patients.

    Methods:

    To test whether dystrophin mutations lead to defective cardiac NaV1.5–Kir2.1 channelosomes and arrhythmias, we generated iPSC-CMs from two hemizygous DMD males, a heterozygous female, and two unrelated control males. We conducted studies including confocal microscopy, protein expression analysis, patch-clamping, non-viral piggy-bac gene expression, optical mapping and contractility assays.

    Results:

    Two patients had abnormal ECGs with frequent runs of ventricular tachycardia. iPSC-CMs from all DMD patients showed abnormal action potential profiles, slowed conduction velocities, and reduced sodium (INa) and inward rectifier potassium (IK1) currents. Membrane NaV1.5 and Kir2.1 protein levels were reduced in hemizygous DMD iPSC-CMs but not in heterozygous iPSC-CMs. Remarkably, transfecting just one component of the dystrophin protein complex (α1-syntrophin) in hemizygous iPSC-CMs from one patient restored channelosome function, INa and IK1 densities, and action potential profile in single cells. In addition, α1-syntrophin expression restored impulse conduction and contractility and prevented reentrant arrhythmias in hiPSC-CM monolayers.

    Conclusions:

    We provide the first demonstration that iPSC-CMs reprogrammed from skin fibroblasts of DMD patients with cardiomyopathy have a dysfunction of the NaV1.5–Kir2.1 channelosome, with consequent reduction of cardiac excitability and conduction. Altogether, iPSC-CMs from patients with DMD cardiomyopathy have a NaV1.5–Kir2.1 channelosome dysfunction, which can be rescued by the scaffolding protein α1-syntrophin to restore excitability and prevent arrhythmias.

    Funding:

    Supported by National Institutes of Health R01 HL122352 grant; ‘la Caixa’ Banking Foundation (HR18-00304); Fundación La Marató TV3: Ayudas a la investigación en enfermedades raras 2020 (LA MARATO-2020); Instituto de Salud Carlos III/FEDER/FSE; Horizon 2020 - Research and Innovation Framework Programme GA-965286 to JJ; the CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). American Heart Association postdoctoral fellowship 19POST34380706s to JVEN. Israel Science Foundation to OB and MA [824/19]. Rappaport grant [01012020RI]; and Niedersachsen Foundation [ZN3452] to OB; US-Israel Binational Science Foundation (BSF) to OB and TH [2019039]; Dr. Bernard Lublin Donation to OB; and The Duchenne Parent Project Netherlands (DPPNL 2029771) to OB. National Institutes of Health R01 AR068428 to DM and US-Israel Binational Science Foundation Grant [2013032] to DM and OB.

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics

    CAMSAP2 organizes a γ-tubulin-independent microtubule nucleation centre through phase separation

    Tsuyoshi Imasaki et al.
    Research Article

    Microtubules are dynamic polymers consisting of αβ-tubulin heterodimers. The initial polymerization process, called microtubule nucleation, occurs spontaneously via αβ-tubulin. Since a large energy barrier prevents microtubule nucleation in cells, the γ-tubulin ring complex is recruited to the centrosome to overcome the nucleation barrier. However, a considerable number of microtubules can polymerize independently of the centrosome in various cell types. Here, we present evidence that the minus-end-binding calmodulin-regulated spectrin-associated protein 2 (CAMSAP2) serves as a strong nucleator for microtubule formation by significantly reducing the nucleation barrier. CAMSAP2 co-condensates with αβ-tubulin via a phase separation process, producing plenty of nucleation intermediates. Microtubules then radiate from the co-condensates, resulting in aster-like structure formation. CAMSAP2 localizes at the co-condensates and decorates the radiating microtubule lattices to some extent. Taken together, these in vitro findings suggest that CAMSAP2 supports microtubule nucleation and growth by organizing a nucleation centre as well as by stabilizing microtubule intermediates and growing microtubules.

    1. Cell Biology
    2. Developmental Biology

    TUBA1A tubulinopathy mutants disrupt neuron morphogenesis and override XMAP215/Stu2 regulation of microtubule dynamics

    Katelyn J Hoff et al.
    Research Article Updated

    Heterozygous, missense mutations in α- or β-tubulin genes are associated with a wide range of human brain malformations, known as tubulinopathies. We seek to understand whether a mutation’s impact at the molecular and cellular levels scale with the severity of brain malformation. Here, we focus on two mutations at the valine 409 residue of TUBA1A, V409I, and V409A, identified in patients with pachygyria or lissencephaly, respectively. We find that ectopic expression of TUBA1A-V409I/A mutants disrupt neuronal migration in mice and promote excessive neurite branching and a decrease in the number of neurite retraction events in primary rat neuronal cultures. These neuronal phenotypes are accompanied by increased microtubule acetylation and polymerization rates. To determine the molecular mechanisms, we modeled the V409I/A mutants in budding yeast and found that they promote intrinsically faster microtubule polymerization rates in cells and in reconstitution experiments with purified tubulin. In addition, V409I/A mutants decrease the recruitment of XMAP215/Stu2 to plus ends in budding yeast and ablate tubulin binding to TOG (tumor overexpressed gene) domains. In each assay tested, the TUBA1A-V409I mutant exhibits an intermediate phenotype between wild type and the more severe TUBA1A-V409A, reflecting the severity observed in brain malformations. Together, our data support a model in which the V409I/A mutations disrupt microtubule regulation typically conferred by XMAP215 proteins during neuronal morphogenesis and migration, and this impact on tubulin activity at the molecular level scales with the impact at the cellular and tissue levels.